HomeMREO • NASDAQ
Mereo BioPharma Group plc - ADR
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.87M | 7.89% |
Net income | -7.02M | 53.18% |
Net profit margin | — | — |
Earnings per share | -0.01 | 51.09% |
EBITDA | -9.82M | -9.13% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.70M | -39.52% |
Total assets | 53.60M | -39.60% |
Total liabilities | 7.00M | -56.79% |
Total equity | 46.60M | — |
Shares outstanding | 159.13M | — |
Price to book | 6.28 | — |
Return on assets | -42.45% | — |
Return on capital | -48.49% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.02M | 53.18% |
Cash from operations | -7.31M | 2.79% |
Cash from investing | 300.00K | — |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -7.43M | -7.50% |
Free cash flow | -3.93M | 29.06% |
Previous close
$1.82
Day range
$1.84 - $1.90
Year range
$1.48 - $3.94
Market cap
1.47B USD
Avg Volume
1.46M
P/E ratio
-
Dividend yield
-
About
Founded
2015
Website
Employees
36
